Does a proactive procedure lead to a higher uptake of predictive testing in families with a pathogenic BRCA1 / BRCA2 variant? A family cancer clinic evaluation
Journal of Genetic Counseling · 2024
DOI: 10.1002/jgc4.1767 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Genetic Counseling, 2024. Verfasst von Fred H Menko und 8 weiteren Autor:innen. Beteiligte Einrichtung: Family Cancer Clinic, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Genetic Testing, Genetic Counseling, BRCA1 Protein, BRCA2 Protein. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 17 Literaturangaben.
Abstract (Originalsprache)
The uptake of genetic counseling and predictive genetic testing by family members at risk for hereditary tumor syndromes is generally below 50%. To address this issue, a new guideline was introduced in the Netherlands in 2019 that aims to improve the sharing of information within families. In addition to cascade screening supported by follow‐up telephone calls with the proband, municipal records were accessed to allow the geneticist to contact at‐risk family members directly. We evaluated this procedure in 32 families with a (likely) pathogenic germline BRCA1/BRCA2 variant diagnosed at our hospital between May 1, 2020, and July 31, 2021, comparing current uptake with outcomes achieved for 33 families diagnosed in 2014. Fifteen months after diagnostic testing of the proband, the uptake was 43% (120/277), comparable to the 44% (87/200) registered previously. Among a subgroup of women at 50% risk aged 25–75 years, 71% (47/66) were tested, comparable to an earlier uptake of 69% (59/86). Of the 34 at‐risk relatives we contacted directly, 17 (50%) underwent predictive testing. In conclusion, we found no evidence that the new procedure leads to a substantially increased uptake. Future research should be primarily aimed at understanding intrafamilial communication barriers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Family Cancer Clinic, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
- Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
ORCID-Profile: Fred H Menko
Zitieren
APA
Menko, F. H., van der Velden, S. L., Griffioen, D. N., Ait Moha, D., Jeanson, K. N., Hogervorst, F. B. L., Giesbertz, N. A. A., Bleiker, E. M. A., & van der Kolk, L. E. (2024). Does a proactive procedure lead to a higher uptake of predictive testing in families with a pathogenic BRCA1 / BRCA2 variant? A family cancer clinic evaluation. Journal of Genetic Counseling. https://doi.org/10.1002/jgc4.1767
Vancouver
Menko FH, van der Velden SL, Griffioen DN, Ait Moha D, Jeanson KN, Hogervorst FBL, et al. Does a proactive procedure lead to a higher uptake of predictive testing in families with a pathogenic BRCA1 / BRCA2 variant? A family cancer clinic evaluation. Journal of Genetic Counseling. 2024. doi:10.1002/jgc4.1767
BibTeX
@article{Menko2024,
author = {Menko, Fred H and van der Velden, Sophie L and Griffioen, Diana N and Ait Moha, Daoud and Jeanson, Kiki N and Hogervorst, Frans B L and Giesbertz, Noor A A and Bleiker, Eveline M A and van der Kolk, Lizet E},
title = {Does a proactive procedure lead to a higher uptake of predictive testing in families with a pathogenic BRCA1 / BRCA2 variant? A family cancer clinic evaluation},
journal = {Journal of Genetic Counseling},
year = {2024},
doi = {10.1002/jgc4.1767}
}
EUVIMED